Newswise — Chicago, IL (June 27, 2016): Advanced level oncology pharmacists seeking quality educational opportunities to meet their Board Certified Oncology Pharmacy (BCOP) recertification requirements will find the highly rated Conference Programming Specialty Sessions Repeat a great option. The Conference Programming Specialty Sessions Repeat ensures that all topics and domains are covered, as specified by the Board of Pharmacy Specialties and the Oncology Pharmacy Specialty Council. Attendees can earn up to 8 credit hours toward BCOP and/or Accreditation Council for Pharmacy credit.

Originally presented at the HOPA Annual Conference, the following sessions will be presented again live in Chicago on September 22, 2016, at the Chicago Marriott O’Hare:

• Haploidentical Stem Cell Transplant: “Alternative” or “Emerging Standard?” • Deciphering the Code for Triple Negative Breast Cancer • Relapsed and Refractory Adult B-Cell Acute Lymphoblastic Leukemia • Study Design and Interpretation •Slow but Persistent...Update on Advancements in the Treatment of Advanced Ovarian Cancer • Myelodysplastic Syndrome • Medical Marijuana • Advances in Immuno-Oncology

Take advantage of the early-bird discounted rates and register by August 22. Special rates for members, groups, and students are available. The 4th Annual Oncology Pharmacy Practice Management Program will take place immediately following on September 23-24 at the same location. Visit www.hoparx.org for a complete details on both events, schedule, faculty information, travel details, and online registration or call HOPA Member Services at 877.467.2791.

HOPA

HOPA is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has more than 2,500 members and includes oncology pharmacists, as well as pharmacy administrators, researchers, residents, interns and technicians specializing in hematology/oncology practice.

###